Γ

SynBioBeta Speaker

Fran Antequera

ATG SynBio Spain

Founder & President

Fran Antequera is a bioeconomy strategist working across agrifood, biomaterials and climate innovation at the intersection of venture building and ecosystem development. He serves as Director of the AgriTech Hub at Misión Andalucía (Government of Andalusia, Spain), is Founder & President of ATG SynBio Spain, and acts as Deal Flow Manager & Project Manager at Ivoro Ventures within the EIT Food Seedbed Venture Catalyst.His work focuses on accelerating the adoption of biosolutions by aligning scientific innovation with market validation, industry uptake and investment readiness. He supports startups in partnerships, internationalization and go-to-market strategy, while fostering collaboration between corporates, research institutions, policymakers and investors.Fran has contributed to international biotechnology strategy through engagements linked to NATO, collaboration with U.S. Navy biotech leadership, and participation in working groups within the Engineering Biology Research Consortium (EBRC), helping map key stakeholders and strengthen transatlantic dialogue in synthetic biology. He also serves as a Member of the External Expert Advisory Board (EEAB) for Agro4Agri, an EU-funded consortium advancing next-generation bio-based solutions for sustainable agriculture.At SynBioBeta, Fran brings a systems-level perspective on how bio-based innovation can move from promising science to scalable impact — by addressing incentive structures, stakeholder alignment and the practical conditions required for real-world deployment across climate, materials and agrifood systems.

Sessions Featuring

Fran

This Year

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include